These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10227175

  • 1. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
    Caroff N, Espaze E, Bérard I, Richet H, Reynaud A.
    FEMS Microbiol Lett; 1999 Apr 15; 173(2):459-65. PubMed ID: 10227175
    [Abstract] [Full Text] [Related]

  • 2. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
    Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor AE, Paton S, Mulvey MR, Canadian Nosocomial Infection Surveillance Program.
    FEMS Microbiol Lett; 2007 May 15; 270(2):265-71. PubMed ID: 17326753
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S, Kraakman M, van Boxtel R, Kors I, Wessels E, Goessens W, Tommassen J, Bernards A.
    Microb Drug Resist; 2015 Feb 15; 21(1):7-16. PubMed ID: 25188329
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C.
    J Antimicrob Chemother; 2005 Dec 15; 56(6):1107-10. PubMed ID: 16239288
    [Abstract] [Full Text] [Related]

  • 7. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
    Siu LK, Lu PL, Chen JY, Lin FM, Chang SC.
    Antimicrob Agents Chemother; 2003 Jul 15; 47(7):2138-44. PubMed ID: 12821459
    [Abstract] [Full Text] [Related]

  • 8. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E, Gibbs M, Clouting C, Barker L, Clifton-Hadley FA, Pleydell E, Abdalhamid B, Hanson ND, Martin L, Poppe C, Davies RH.
    Microb Drug Resist; 2004 Jul 15; 10(1):1-9. PubMed ID: 15140388
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, Walsh TR, Sundsfjord A, Lundblad EW.
    J Antimicrob Chemother; 2008 Oct 15; 62(4):694-702. PubMed ID: 18583329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 15; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 13. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis.
    Peter-Getzlaff S, Polsfuss S, Poledica M, Hombach M, Giger J, Böttger EC, Zbinden R, Bloemberg GV.
    J Clin Microbiol; 2011 Aug 15; 49(8):2924-32. PubMed ID: 21653764
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
    Mammeri H, Nazic H, Naas T, Poirel L, Léotard S, Nordmann P.
    Antimicrob Agents Chemother; 2004 Oct 15; 48(10):4050-3. PubMed ID: 15388478
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and molecular characterization of AmpC-producing clinical isolates of Escherichia coli from southeastern Iran.
    Shayan S, Bokaeian M, Shahraki S.
    Microb Drug Resist; 2014 Apr 15; 20(2):104-7. PubMed ID: 24224496
    [Abstract] [Full Text] [Related]

  • 20. [Detection of plasmid-mediated AmpC beta-lactamase in clinical isolates of cefoxitin-resistant Escherichia coli and Klebsiella pneumoniae].
    Coşkun S, Altanlar N.
    Mikrobiyol Bul; 2012 Jul 15; 46(3):375-85. PubMed ID: 22951650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.